Pradaxa

Boehringer Ingelheim Pharma GmbH & Co. KG🇵🇭 Food and Drug Administration - Philippines

Approval Id: 4a13ffc3fc48cfbb
Drug Approval Philippines Name: Pradaxa
Product Name: Pradaxa
Registration Number: DRP-7436
Brand Name: Pradaxa
Generic Name: Dabigatran Etexilate
Dosage Form: Capsule
Dosage Strength: 110mg
Manufacturer: Boehringer Ingelheim Pharma GmbH & Co. KG
Importer: Boehringer Ingelheim (Philippines), Inc.
Company Detail Path: /organization/boehringer-ingelheim-pharma-gmbh-and-co-kg
Issuance Date: 24 January 2024
Expiry Date: 30 January 2029
Pharmacologic Category: Direct Thrombin Inhibitors
Classification: Prescription Drug (RX)

Approved

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

4a13ffc3fc48cfbb

Type

Standard